Cornerstone Advisors’s Allergan plc AGN Stock Holding History

Cornerstone Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-12,400	Closed	-$1.66M	–	242
2018 Q4	$1.66M	Sell	12,400 -6,900	-36%	-$1.13M	0.15%	152
2018 Q3	$3.68M	Buy	19,300 +13,000	+206%	+$2.39M	0.26%	106
2018 Q2	$1.05M	Hold	6,300	–	–	0.13%	152
2018 Q1	$1.06M	Hold	6,300	–	–	0.13%	166
2017 Q4	$1.03M	Hold	6,300	–	–	0.12%	183
2017 Q3	$1.29M	Hold	6,300	–	–	0.15%	175
2017 Q2	$1.53M	Hold	6,300	–	–	0.28%	95
2017 Q1	$1.5M	Buy	+6,300	New	+$1.47M	0.27%	89
2016 Q2	–	Sell	-9,681	Closed	-$2.6M	–	233
2016 Q1	$2.6M	Hold	9,681	–	–	0.63%	47
2015 Q4	$3.02M	Hold	9,681	–	–	0.7%	38
2015 Q3	$2.63M	Buy	9,681 +1,000	+12%	+$307K	0.62%	44
2015 Q2	$2.63M	Sell	8,681 -2	-0%	-$597	0.59%	54
2015 Q1	$2.58M	Buy	8,683 +3,683	+74%	+$1.05M	0.53%	54
2014 Q4	$1.29M	Hold	5,000	–	–	0.26%	109
2014 Q3	$1.21M	Hold	5,000	–	–	0.24%	122
2014 Q2	$1.11M	Buy	+5,000	New	+$1.04M	0.22%	135

Other funds holding AGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cornerstone Advisors's AGN Position: Q1 2019 in Review

Cornerstone Advisors sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 12,400 shares — an estimated $1.66M sold.

Cornerstone Advisors first reported a position in AGN in Q2 2014 and held it in 16 quarters. The position peaked at $3.68M in Q3 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

Cornerstone Advisors reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
Cornerstone Advisors sold 12,400 Allergan plc shares in Q1 2019, an estimated $1.66M.
Cornerstone Advisors first reported a position in Allergan plc in Q2 2014 and held it in 16 quarters.
Cornerstone Advisors's Allergan plc position peaked at $3.68M in Q3 2018.
991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Cornerstone Advisors's 13F filing for Q1 2019, filed 9 May 2019.